Cited by 721Metabolism, Diabetes, and CancerDiabetes Treatment and ManagementNatural Antidiabetic Agents Studies

The DOI matches its Crossref record; 258 of the 261 references it cites were found in a registry or an index.

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

Open access

Foretz, Marc, Guigas, Bruno, Viollet, Benoit·2019·Nature Reviews Endocrinology

Open this paper in CoChat — free account

Abstract

Despite its position as the first-line drug for treatment of type 2 diabetes mellitus, the mechanisms underlying the plasma glucose level-lowering effects of metformin (1,1-dimethylbiguanide) still remain incompletely understood. Metformin is thought to exert its primary antidiabetic action through the suppression of hepatic glucose production. In addition, the discovery that metformin inhibits the mitochondrial respiratory chain complex 1 has placed energy metabolism and activation of AMP-activated protein kinase (AMPK) at the centre of its proposed mechanism of action. However, the role of AMPK has been challenged and might only account for indirect changes in hepatic insulin sensitivity. Various mechanisms involving alterations in cellular energy charge, AMP-mediated inhibition of adenylate cyclase or fructose-1,6-bisphosphatase 1 and modulation of the cellular redox state through direct inhibition of mitochondrial glycerol-3-phosphate dehydrogenase have been proposed for the acute inhibition of gluconeogenesis by metformin. Emerging evidence suggests that metformin could improve obesity-induced meta-inflammation via direct and indirect effects on tissue-resident immune cells in metabolic organs (that is, adipose tissue, the gastrointestinal tract and the liver). Furthermore, the gastrointestinal tract also has a major role in metformin action through modulation of glucose-lowering hormone glucagon-like peptide 1 and the intestinal bile acid pool and alterations in gut microbiota composition.

Integrity signals

Registry

Crossref · 10.1038/s41574-019-0242-2

Cites

258 of 258 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Items 201–258 of 258

Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon‐like peptide‐1 secretion
Hansen, M., Scheltema, M. J. V., Sonne, D. P., Hansen, J. S., Sperling, M., Rehfeld, J. F., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12648 · Cited by 95
[11C]-Labeled Metformin Distribution in the Liver and Small Intestine Using Dynamic Positron Emission Tomography in Mice Demonstrates Tissue-Specific Transporter Dependency
Jensen, J., Sundelin, E. I. O., Jakobsen, S., Gormsen, L. C., Munk, O. L., Frøkiær, J., & Jessen, N. (2016) · Diabetes · doi:10.2337/db16-0032 · Cited by 91
Metformin: New Preparations and Nonglycemic Benefits
Fujita, Y., & Inagaki, N. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0829-8 · Cited by 91
Metformin treatment significantly enhances intestinal glucose uptake in patients with type 2 diabetes: Results from a randomized clinical trial
Koffert, J., Mikkola, K., Virtanen, K. A., Andersson, A. D., Faxius, L., Hällsten, K., Heglind, M., Guiducci, L., Pham, T. T., Silvola, J. M. U., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.015 · Cited by 91
Studies on the Mitochondrial α-Glycerophosphate Dehydrogenase
Ringler, R. L., & Singer, T. P. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69892-8 · Cited by 90
Establishment of a Database of Metformin Plasma Concentrations and Erythrocyte Levels in Normal and Emergency Situations
Lalau, J., Lemaire‐Hurtel, A., & Lacroix, C. (2011) · Clinical Drug Investigation · doi:10.2165/11588310-000000000-00000 · Cited by 87
Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism
Alshawi, A., & Agius, L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006670 · Cited by 87
Subcellular Distribution of Metformin in Rat Liver
Wilcock, C., Wyre, N. D., & Bailey, C. J. (1991) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1991.tb03507.x · Cited by 86
Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling
Rosário, D., Benfeitas, R., Bidkhori, G., Zhang, C., Uhlén, M., Shoaie, S., & Mardinoğlu, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00775 · Cited by 86
Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects
Bonora, E., CIGOLINI, M., Bosello, O., Zancanaro, C., Capretti, L., Zavaroni, I., Coscelli, C., & BUTTURINI, U. (1984) · Current Medical Research and Opinion · doi:10.1185/03007998409109558 · Cited by 85
GUANIDINES AND OXIDATIVE PHOSPHORYLATIONS
Hollunger, G. (1955) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1955.tb02972.x · Cited by 84
Citrin/Mitochondrial Glycerol-3-phosphate Dehydrogenase Double Knock-out Mice Recapitulate Features of Human Citrin Deficiency
Saheki, T., Iijima, M., Li, M. X., Kobayashi, K., Horiuchi, M., Ushikai, M., Okumura, F., Meng, X. J., Inoue, I., Tajima, A., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702031200 · Cited by 83
Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase
Bridges, H. R., Sirviö, V. A., Agip, A.-N. A., & Hirst, J. (2016) · BMC Biology · doi:10.1186/s12915-016-0287-9 · Cited by 82
Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels
Burton, J. H., Johnson, M., Johnson, J. L., Hsia, D. S., Greenway, F. L., & Heiman, M. L. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815577425 · Cited by 81
Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes
Wu, T., Xie, C., Wu, H., Jones, K. L., Horowitz, M., & Rayner, C. K. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12812 · Cited by 79
Mitochondrial Targeting of Metformin Enhances Its Activity against Pancreatic Cancer
Boukalová, Š., Štursa, J., Werner, L., Ezrova, Z., Černý, J., Bezawork‐Geleta, A., Pecinová, A., Dong, L., Drahota, Z., & Neužil, J. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-1021 · Cited by 76
Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response
Pereira, F. V., de Melo, A. C. L., Low, J. S., de Castro, Í. A., Braga, T. T., de Almeida, D. C., de Lima, A. G. U. B., Hiyane, M. I., Corrêa-Costa, M., Andrade‐Oliveira, V., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25380 · Cited by 75
Inducing cancer indolence by targeting mitochondrial Complex I is potentiated by blocking macrophage-mediated adaptive responses
Kurelac, I., Iommarini, L., Vatrinet, R., Amato, L. B., Luise, M. D., Leone, G., Girolimetti, G., Ganesh, N. U., Bridgeman, V. L., Ombrato, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08839-1 · Cited by 75
Involvement of glucagon‐like peptide‐1 in the glucose‐lowering effect of metformin
Bahne, E., Hansen, M., Brønden, A., Sonne, D. P., Vilsbøll, T., & Knop, F. K. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12697 · Cited by 73
Control of Gluconeogenesis by Metformin: Does Redox Trump Energy Charge?
Baur, J. A., & Birnbaum, M. J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.013 · Cited by 72
An Update on the Pharmacogenomics of Metformin: Progress, Problems and Potential
Todd, J. N., & Florez, J. C. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.21 · Cited by 72
Metformin-induced regulation of the intestinal D-glucose transporters.
Sakar, Y., Meddah, B., Faouzi, M. A., Cherrah, Y., Bado, A., & Ducroc, R. A. (2010) · PubMed · Cited by 72
Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling
Kim, M.-H., Jee, J.-H., Park, S., Lee, M., Kim, K., & Lee, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0381 · Cited by 66
The effects of metformin on inflammatory mediators in obese adolescents with insulin resistance: controlled randomized clinical trial
Evia-Viscarra, M. L., Rodea-Montero, E. R., Apolinar‐Jiménez, E., Muñoz-Noriega, N., García-Morales, L. M., Leaños-Pérez, C., Figueroa-Barrón, M., Sánchez-Fierros, D., & Reyes‐García, G. (2012) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2011-0469 · Cited by 65
New Insights Into the Anti-Diabetic Actions of Metformin: From the Liver to the Gut
Wu, T., Horowitz, M., & Rayner, C. K. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1273769 · Cited by 64
Glucoregulatory Relevance of Small Intestinal Nutrient Sensing in Physiology, Bariatric Surgery, and Pharmacology
Duca, F. A., Bauer, P. V., Hamr, S. C., & Lam, T. K. T. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.003 · Cited by 62
Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis
Vashisht, R., & Brahmachari, S. K. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0443-y · Cited by 62
Site-specific uncoupling and inhibition of oxidative phosphorylation by biguanides. II
Schäfer, G. (1969) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(69)90077-2 · Cited by 61
Pharmacokinetics of metformin in patients with gastrointestinal intolerance
MCCREIGHT, L. J., Stage, T. B., Connelly, P. J., Lonergan, M. E., Nielsen, F., Prehn, C. P., Adamski, J., Brøsen, K., & Pearson, E. R. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13264 · Cited by 59
Effect of Serotonin Transporter 5-HTTLPR Polymorphism on Gastrointestinal Intolerance to Metformin: A GoDARTS Study
Dujić, T., Zhou, K., Tavendale, R., Palmer, C. N. A., & Pearson, E. R. (2016) · Diabetes Care · doi:10.2337/dc16-0706 · Cited by 56
Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials
Meng, H., Zhang, A., Liang, Y., Hao, J., Zhang, X., & Lu, J. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2983 · Cited by 56
Differential effects of metformin on bile salt absorption from the jejunum and ileum
Carter, D., Howlett, H. C. S., Wiernsperger, N. F., & Bailey, C. J. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00252.x · Cited by 54
Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria
Guo, Z., Sevrioukova, I. F., Denisov, I. G., Zhang, X., Chiu, T.-L., Thomas, D. G., Hanse, E. A., Cuellar, R. A. D., Grinkova, Y. V., Langenfeld, V. W., et al. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.08.009 · Cited by 54
Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women
Tosi, F., Negri, C., Brun, E., Castello, R., Faccini, G., Bonora, E., Muggeo, M., Toscano, V., & Moghetti, P. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0782 · Cited by 53
Metformin protects against lipoapoptosis and enhances GLP-1 secretion from GLP-1-producing cells
Krizhanovskii, C., Patrone, C., Holst, J. J., Zhang, Q., & Sjöholm, Å. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0637-5 · Cited by 51
Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon‐like peptide‐1, and gastric emptying after oral glucose, in type 2 diabetes
Borg, M. J., Bound, M. J., Grivell, J., Sun, Z., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13567 · Cited by 50
Effects of metformin on SGLT1, GLUT2, and GLUT5 hexose transporter gene expression in small intestine from rats
Lenzen, S., Lortz, S., & Tiedge, M. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02243-0 · Cited by 48
Metformin suppresses UHMWPE particle-induced osteolysis in the mouse calvaria by promoting polarization of macrophages to an anti-inflammatory phenotype
Zhao, Y., Tian, X., Zhu, J., Lu, Z., Yu, L., Zhang, D., Liu, Y., Yang, C., Zhu, Q., & Cao, X. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0013-x · Cited by 45
Single-Dose Metformin Enhances Bile Acid–Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes
Brønden, A., Albèr, A., Rohde, U., Rehfeld, J. F., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01091 · Cited by 43
A novel cobiotic containing a prebiotic and an antioxidant augments the glucose control and gastrointestinal tolerability of metformin: a case report
Greenway, F. L., Wang, S., & Heiman, M. L. (2013) · Beneficial Microbes · doi:10.3920/bm2012.0063 · Cited by 40
Ondansetron and Metformin-Induced Gastrointestinal Side Effects
Hoffmann, I., Roa, M., Torrico, F., & Cubeddu, L. X. (2003) · American Journal of Therapeutics · doi:10.1097/00045391-200311000-00012 · Cited by 39
Inhibition of the multidrug and toxin extrusion ( MATE ) transporter by pyrimethamine increases the plasma concentration of metformin but does not increase antihyperglycaemic activity in humans
Oh, J., Chung, H., Park, S., Yi, S., Jang, K., Kim, A., Yoon, J., Cho, J., Yoon, S. H., Jang, I., et al. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12577 · Cited by 38
Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver
Lu, C., Hung, Y., & Hsieh, P. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.07.012 · Cited by 38
Annatto-extracted tocotrienols improve glucose homeostasis and bone properties in high-fat diet-induced type 2 diabetic mice by decreasing the inflammatory response
Shen, C., Kaur, G., Wanders, D., Sharma, S., Tomison, M. D., Ramalingam, L., Chung, E., Moustaïd‐Moussa, N., Mo, H., & Dufour, J. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-29063-9 · Cited by 37
Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis
Clarke, J., Dzierlenga, A. L., Nelson, N. R., Li, H., Werts, S. J., Goedken, M. J., & Cherrington, N. J. (2015) · Diabetes · doi:10.2337/db14-1947 · Cited by 34
Efficacy and safety of liraglutide versus sitagliptin both in combination with metformin in patients with type 2 diabetes
Li, M., Yang, Y., Jiang, D.-Q., Ying, M., Wang, Y., & Zhao, R. (2017) · Medicine · doi:10.1097/md.0000000000008161 · Cited by 34
Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes
Henry, R. R., Frías, J. P., Walsh, B., Skare, S., Hemming, J., Burns, C. M., Bicsak, T. A., Baron, A., & Fineman, M. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203946 · Cited by 33
Metformin and respiratory chain complex I: the last piece of the puzzle?
Fontaine, E. M. (2014) · Biochemical Journal · doi:10.1042/bj20141020 · Cited by 29
Opposite effects of a glucokinase activator and metformin on glucose‐regulated gene expression in hepatocytes
Al‐Oanzi, Z. H., Fountana, S., Moonira, T., Tudhope, S. J., Petrie, J. L., Alshawi, A., Patman, G., Arden, C., Reeves, H. L., & Agius, L. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12910 · Cited by 29
Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241–1249
Agrawal, S., & Gupta, Y. (2016) · Diabetes Care · doi:10.2337/dc16-1340 · Cited by 26
Inhibition of upper small intestinal mTOR lowers plasma glucose levels by inhibiting glucose production
Waise, T. M. Z., Rasti, M., Duca, F. A., Zhang, S., Bauer, P. V., Rhodes, C. J., & Lam, T. K. T. (2019) · Nature Communications · doi:10.1038/s41467-019-08582-7 · Cited by 26
The contributions of oestrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome
Carmina, E., González, F., Vidali, A., Stanczyk, F. Z., Ferin, M., & Løbo, R. A. (1999) · Human Reproduction · doi:10.1093/humrep/14.2.307 · Cited by 25
Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria
Guo, Z., Sevrioukova, I. F., Denisov, I. G., Zhang, X., Chiu, T.-L., Thomas, D. G., Hanse, E. A., Cuellar, R. A. D., Grinkova, Y. V., Langenfeld, V. W., et al. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.09.012 · Cited by 16
Will delayed release metformin provide better management of diabetes type 2?
Scheen, A. J. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1149166 · Cited by 15
Alkannin Inhibited Hepatic Inflammation in Diabetic Db/Db Mice
Xue, W., Fan, Z., Li, Y., Li, L., Zhang, T., Lü, J., Ma, B., Zhu, Z., Lian, J., Zhang, C., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488264 · Cited by 15
Metformin: not only per os
Berstein, L. M. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1431123 · Cited by 11
Hyperlactatemia in diabetics with retinopathy during combined sulphonylurea and phenformin therapy.
Nattrass, M., Mj, A., Smythe, P., McGill, J. I., Todd, P. G., & Kg, A. (1978) · PubMed · Cited by 4
Corrigendum to “Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macrophages” [Pharmacol. Rep. 66 (2014) 418–429]
Bułdak, Ł., Łabuzek, K., Bułdak, R. J., Kozłowski, M., Machnik, G., Liber, S., Suchy, D., Duława, A., & Okopień, B. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.02.010 · Cited by 1

Sorted by citations

Insulin Resistance: From Mechanisms to Therapeutic Strategies
Lee, S.-H., Park, S., & Choi, C. S. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0280 · Cited by 1,248
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 799
Metformin: update on mechanisms of action and repurposing potential
Foretz, M., Guigas, B., & Viollet, B. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00833-4 · Cited by 791
Self-citation
Low-dose metformin targets the lysosomal AMPK pathway through PEN2
Ma, T., Tian, X., Zhang, B., Li, M., Wang, Y., Yang, C., Wu, J., Wei, X., Qu, Q., Yu, Y., et al. (2022) · Nature · doi:10.1038/s41586-022-04431-8 · Cited by 644
GDF15 mediates the effects of metformin on body weight and energy balance
Coll, A. P., Chen, M., Taskar, P., Rimmington, D., Patel, S., Tadross, J. A., Cimino, I., Yang, M., Welsh, P., Virtue, S., et al. (2020) · Nature · doi:10.1038/s41586-019-1911-y · Cited by 584

See all 721

Authors: Foretz, M., Guigas, B., & Viollet, B.
Affiliations: Centre National de la Recherche Scientifique (FR)
Leiden University Medical Center (NL)
ORCID: Foretz, Marc
Guigas, Bruno
Viollet, Benoit
Venue: Nature Reviews Endocrinology
Publisher: Springer Science and Business Media LLC
Published: 2019-08-22
Volume: 15
Issue: 10
Pages: 569-589
ISSN: 1759-5029 (ISSN-L)
1759-5037
DOI: 10.1038/s41574-019-0242-2
OpenAlex: W2969928163
Cited by: 686
References: 261
Citations by year: 2026: 80 · 2025: 104 · 2024: 92 · 2023: 122 · 2022: 113 · 2021: 102 · 2020: 68 · 2019: 5
FWCI: 6.34
Type: journal article
Language: en
Open access: green
inserm.hal.science
Licence: other-oa
www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Reviews Endocrinology (publishedVersion)
PubMed (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
HAL (submittedVersion, other-oa)
Leiden Repository (Leiden University) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Keywords: metformin, type 2 diabetes, glucoregulation, hepatic glucose production, gluconeogenesis, AMPK, mitochondrial complex I inhibition, hepatic insulin sensitivity, adenylate cyclase inhibition, FBP1, glycerol-3-phosphate dehydrogenase, redox state, meta-inflammation, obesity, gut microbiota, glucagon-like peptide-1, bile acids
MeSH terms: Gastrointestinal Microbiome, Animals, Diabetes Mellitus, Type 2, Electron Transport, Glucose, Humans, Hypoglycemic Agents, Metformin, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks